As of April 29, 2025, vTv Therapeutics (VTVT) has a market cap of $56.352 million USD. According to our data, vTv Therapeutics is ranked No.8027 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $56.35 M |
56.22%
|
Dec 31, 2024 | $36.07 M |
20.08%
|
Dec 29, 2023 | $30.04 M |
-56.64%
|
Dec 30, 2022 | $69.28 M |
-33.37%
|
Dec 31, 2021 | $0.10 B |
-46.51%
|
Dec 31, 2020 | $0.19 B |
9.41%
|
Dec 31, 2019 | $0.18 B |
-35.85%
|
Dec 31, 2018 | $0.28 B |
-55.91%
|
Dec 29, 2017 | $0.63 B |
24.43%
|
Dec 30, 2016 | $0.50 B |
-29.07%
|
Dec 31, 2015 | $0.71 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$798.85 B |
-0.142 B
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$290.97 B |
71.626 B
|
![]() Denmark
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.59 B |
-0.012 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Biogen
BIIB
|
$17.71 B |
0.001 M
|
![]() USA
|
![]() Novartis
NVS
|
$225.44 B |
0.161 B
|
![]() Switzerland
|
![]() AbbVie
ABBV
|
$345.22 B |
-0.012 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$47.71 B |
-0.002 M
|
![]() Japan
|
Market Cap | = | VTVT Stock Price | * | VTVT Shares Outstanding |
= | $21.57 | * | 2.61 M | |
= | $56.35 M |